| RS1363536856 |
VAC14
|
Health Risk |
Conflicting classifications of pathogenicity |
Striatonigral degeneration, childhood-onset |
| RS1363547577 |
EVC
|
Health Risk |
Likely pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1363559666 |
DDC
|
Health Risk |
Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS1363575527 |
RFX5
|
Health Risk |
Pathogenic/Likely pathogenic |
RFX5-related disorder, MHC class II deficiency |
| RS1363632615 |
TMEM231
|
Health Risk |
Pathogenic |
Joubert syndrome 20, Meckel syndrome |
| RS1363641203 |
EYS
|
Health Risk |
Likely pathogenic |
— |
| RS1363644889 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1363648649 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Rapadilino syndrome |
| RS1363652416 |
TBC1D8B
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 20 |
| RS1363658406 |
RTEL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS1363663761 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, adult type |
| RS1363680371 |
COL4A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS1363688830 |
PCDH15
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1F, Usher syndrome type 1F |
| RS1363689100 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS1363715209 |
LBR
|
Health Risk |
Likely pathogenic |
Pelger-Huët anomaly, Pelger-Huët anomaly |
| RS1363726955 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1363738186 |
MMACHC
|
Health Risk |
Pathogenic |
Cobalamin C disease, Cobalamin C disease |
| RS1363740679 |
SCN1A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1363752047 |
SLC2A1
|
Health Risk |
Pathogenic |
GLUT1 deficiency syndrome 1, autosomal recessive |
| RS1363770105 |
SLC4A11
|
Health Risk |
Pathogenic |
Congenital hereditary endothelial dystrophy of cornea, Corneal dystrophy-perceptive deafness syndrome |
| RS1363776385 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 5, Arrhythmogenic right ventricular dysplasia 5 |
| RS1363815113 |
EXT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple congenital exostosis, Exostoses |
| RS1363836483 |
FRAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 1, Fraser syndrome 1 |
| RS1363846772 |
BBS2
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 2 |
| RS1363855014 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1363883059 |
TBXA2R
|
Health Risk |
Likely pathogenic |
Bleeding disorder, platelet-type |
| RS1363884891 |
CEP76
|
Health Risk |
Likely pathogenic |
Short stature, Short stature |
| RS1363931577 |
PARN
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS1363933594 |
SEPSECS
|
Health Risk |
Pathogenic |
— |
| RS1363946483 |
FANCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1363947528 |
SLC25A13
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia, type II |
| RS1363954556 |
HAAO
|
Health Risk |
Likely pathogenic |
Congenital NAD deficiency disorder, Vertebral |
| RS1363959441 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1363960054 |
UNC13D
|
Health Risk |
Pathogenic |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS1363990917 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiomyopathy |
| RS1363997186 |
SERPING1
|
Health Risk |
Likely pathogenic |
— |
| RS1364005933 |
AP5Z1
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS1364012682 |
SLC34A1
|
Health Risk |
Likely pathogenic |
— |
| RS1364027643 |
SOS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 9, Cardiovascular phenotype |
| RS1364032336 |
CERKL
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 26, Retinitis pigmentosa 26 |
| RS1364033144 |
NFIB
|
Health Risk |
Pathogenic/Likely pathogenic |
Macrocephaly, acquired |
| RS1364046355 |
IVD
|
Health Risk |
Pathogenic/Likely pathogenic |
Isovaleryl-CoA dehydrogenase deficiency, Isovaleryl-CoA dehydrogenase deficiency |
| RS1364046604 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group B |
| RS1364054304 |
DDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of aromatic-L-amino-acid decarboxylase, Deficiency of aromatic-L-amino-acid decarboxylase |
| RS1364055998 |
ADGRV1
|
Health Risk |
Pathogenic |
— |
| RS1364062389 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1364064979 |
LOXHD1
|
Health Risk |
Pathogenic |
— |
| RS1364071684 |
ADARB1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, microcephaly |
| RS1364085211 |
TMTC4
|
Health Risk |
Pathogenic |
Hearing loss, autosomal recessive 122 |
| RS1364087255 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1364101045 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1364156515 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1364192556 |
PGAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
See cases, See cases |
| RS1364200072 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS1364203992 |
NAGLU
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1364210063 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1364214310 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS1364222107 |
ADAR
|
Health Risk |
Pathogenic |
ADAR-related disorder, ADAR-related disorder |
| RS1364238660 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group C, Hereditary cancer-predisposing syndrome |
| RS1364240080 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1364255987 |
ADAMTSL4
|
Health Risk |
Likely pathogenic |
Craniosynostosis with ectopia lentis, Craniosynostosis with ectopia lentis |
| RS1364256214 |
BARD1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1364280797 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS1364297209 |
LRP2
|
Health Risk |
Pathogenic |
Donnai-Barrow syndrome, Donnai-Barrow syndrome |
| RS1364300712 |
SKIC3
|
Health Risk |
Likely pathogenic |
— |
| RS1364312021 |
FANCL
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group L, Fanconi anemia complementation group L |
| RS1364331716 |
USH1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 18A, Usher syndrome type 1C |
| RS1364348923 |
ALPK3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1364382189 |
GPI
|
Health Risk |
Pathogenic |
Hemolytic anemia due to glucophosphate isomerase deficiency, Hemolytic anemia due to glucophosphate isomerase deficiency |
| RS1364396346 |
DHTKD1
|
Health Risk |
Likely pathogenic |
2-aminoadipic 2-oxoadipic aciduria, 2-aminoadipic 2-oxoadipic aciduria |
| RS1364421307 |
NPC1
|
Health Risk |
Pathogenic |
Niemann-Pick disease, type C1 |
| RS1364430470 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1364436691 |
IBA57
|
Health Risk |
Likely pathogenic |
— |
| RS1364444432 |
MYH9
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss |
| RS1364461144 |
LRIG2
|
Health Risk |
Likely pathogenic |
— |
| RS1364462270 |
STXBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1364496996 |
PLP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 2, Inborn genetic diseases |
| RS1364500207 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1364515992 |
MAT1A
|
Health Risk |
Pathogenic |
Hepatic methionine adenosyltransferase deficiency, Hepatic methionine adenosyltransferase deficiency |
| RS1364533250 |
NBN
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS1364540701 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS1364541592 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1364547914 |
GJA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Atrial standstill 1, Atrial fibrillation |
| RS1364550008 |
TTN;TTN-AS1
|
Health Risk |
Likely pathogenic |
— |
| RS1364581133 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1364587778 |
POMGNT1
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1364598710 |
KBTBD13
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 6, Nemaline myopathy 6 |
| RS1364608764 |
CENPT
|
Health Risk |
Pathogenic |
Short stature and microcephaly with genital anomalies, Short stature and microcephaly with genital anomalies |
| RS1364609203 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1364614470 |
PEX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder, Heimler syndrome 2 |
| RS1364618100 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS1364649058 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate E, Focal segmental glomerulosclerosis 5 |
| RS1364684686 |
KLHL41
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 9, Nemaline myopathy 9 |
| RS1364690005 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, Global developmental delay |
| RS1364707671 |
ADGRV1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1364708195 |
HNF1A
|
Health Risk |
Pathogenic |
Monogenic diabetes, Maturity-onset diabetes of the young |
| RS1364709483 |
TBX2
|
Health Risk |
Pathogenic/Likely pathogenic |
TBX2-related disorder, Vertebral anomalies and variable endocrine and T-cell dysfunction |
| RS1364714267 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1364719732 |
RMRP
|
Health Risk |
Likely pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1364738194 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Familial isolated arrhythmogenic right ventricular dysplasia |